Health insurance should cover non-clinically effective generic products, KPMA says

The government is considering the conditional permit of some non-clinically effective generic drugs, but the Korea Pharmaceutical Manufacturers Association says that the clinical effectiveness of such drugs should be evaluated by that of oringal brands.

The positive list system stipulates a strict screening process of conventional drugs eligible for national health insurance reimbursement. I...